Covaxin had much lower adverse effects and overall favourable short-term safety profile in adolescents: Study

May 21, 2024
These were the findings of a study conducted by researchers at Benaras Hindu University on adolescent (15-18 years) and adult (over 19 years) recipients of Covaxin that claims to be the first real-world safety analysis of Covaxin.